Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / MRNA - Novavax Vs. Moderna Stock: Which Is The Better Buy?

MRNA - Novavax Vs. Moderna Stock: Which Is The Better Buy?

Moderna Inc.
  • Moderna is the most effective COVID-19 vaccine, based on the latest CDC data.
  • Moderna has applied for full approval from the US FDA and is awaiting its EUA for booster shots.
  • Novavax has filed for EUL from WHO and expects to file for EUA from the US FDA in Q4'21.
  • Moderna has 1.1B doses from APA for 2022, as compared to 450M doses for Novavax.
  • We discuss in this article which is the better buy for investors now.

For further details see:

Novavax Vs. Moderna Stock: Which Is The Better Buy?
Stock Information
Company Name: Moderna Inc.
Stock Symbol: MRNA
Market: NASDAQ
Website: modernatx.com
Menu
MRNA MRNA Quote MRNA Short MRNA News MRNA Articles MRNA Message Board
Get MRNA Alerts

News, Short Squeeze, Breakout and More Instantly...